Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study
Titel:
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study
Auteur:
Kumar, Princy Clarke, Amanda E. Jonsson-Oldenbüttel, Celia Deltoro, Miguel García Di Giambenedetto, Simona Brites, Carlos Hocqueloux, Laurent Lu, Po-Liang Oyee, James Oglesby, Alan Wynne, Brian Jones, Bryn Evitt, Lee A. Fox, Dainielle Kisare, Michelle Priest, Julie